[go: up one dir, main page]

BR9811473A - Infecção por rinovìrus inibida por óxido nìtrico - Google Patents

Infecção por rinovìrus inibida por óxido nìtrico

Info

Publication number
BR9811473A
BR9811473A BR9811473-5A BR9811473A BR9811473A BR 9811473 A BR9811473 A BR 9811473A BR 9811473 A BR9811473 A BR 9811473A BR 9811473 A BR9811473 A BR 9811473A
Authority
BR
Brazil
Prior art keywords
nitric oxide
inhibited
synthesis
inhibit
infection inhibited
Prior art date
Application number
BR9811473-5A
Other languages
English (en)
Inventor
Scherer P Sanders
David Proud
Original Assignee
Univ Johns Hopkins Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Johns Hopkins Med filed Critical Univ Johns Hopkins Med
Publication of BR9811473A publication Critical patent/BR9811473A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

"INFECçãO POR RINOVìRUS INIBIDA POR óXIDO NìTRICO".óxido Nítrico gerando compostos ou compostos que produzem insitu síntese de óxido nítrico podem ser usado para inibir infecçãopor rinovírus. O óxido nítrico produz a capacidade para inibir tantoa replicação viral quanto a sintese de citocinas em particular ascitocinas pró-inflamatórias. Assim os sintomas das infecções porrinovírus podem ser aperfeiçoados por tratamentos com oacréscimo de óxido nítrico no tratamento respiratório.
BR9811473-5A 1997-07-11 1998-07-10 Infecção por rinovìrus inibida por óxido nìtrico BR9811473A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5230797P 1997-07-11 1997-07-11
PCT/US1998/014466 WO1999002148A1 (en) 1997-07-11 1998-07-10 Nitric oxide inhibits rhinovirus infection

Publications (1)

Publication Number Publication Date
BR9811473A true BR9811473A (pt) 2001-12-26

Family

ID=21976738

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9811473-5A BR9811473A (pt) 1997-07-11 1998-07-10 Infecção por rinovìrus inibida por óxido nìtrico

Country Status (14)

Country Link
US (1) US6277891B1 (pt)
EP (1) EP1011657A1 (pt)
JP (1) JP2001509481A (pt)
KR (1) KR20010021749A (pt)
CN (1) CN1277552A (pt)
AU (1) AU8399098A (pt)
BR (1) BR9811473A (pt)
CA (1) CA2303430A1 (pt)
CZ (1) CZ200092A3 (pt)
HU (1) HUP0002859A2 (pt)
ID (1) ID23780A (pt)
NO (1) NO20000151L (pt)
TR (1) TR200000157T2 (pt)
WO (1) WO1999002148A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030753A1 (es) * 2000-09-25 2003-09-03 Smithkline Beecham Corp Uso de moduladores-proteina de il-8, groalfa, grobeta, grogamma, nap-2, y ena-78, para tratar infecciones viricas
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
DE10303196A1 (de) * 2003-01-28 2004-08-12 Märtz, Hans Helmut Verwendung von Erzeugnissen, Stoffen oder Stoffgemischen, aus welchen im menschlichen oder tierischen Körper Stickoxid (Formel: NO) entsteht, zur Behandlung oder Prophylaxe von Infektionskrankheiten des menschlichen oder tierischen Körpers
SE0300971D0 (sv) * 2003-04-03 2003-04-03 Aga Ab Nitric oxide in treatment of inflammation
CA2537222A1 (en) 2003-07-09 2005-01-27 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of nitrite salts for the treatment of cardiovascular conditions
US8252591B2 (en) 2004-05-07 2012-08-28 Whitehead Institute For Biomedical Research Hormone responsive tissue culture system and uses thereof
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
WO2006125123A2 (en) 2005-05-19 2006-11-23 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
GB0607402D0 (en) * 2006-04-12 2006-05-24 Barts & London Nhs Trust Therapeutic composition and use
EP2188367A4 (en) 2007-08-10 2010-10-27 Whitehead Biomedical Inst HORMON'S TREATIVE TISSUE CULTURE SYSTEM AND USES THEREOF
EP2237788A4 (en) * 2007-12-27 2013-06-05 Aires Pharmaceuticals Inc COMPOUNDS FOR OBTAINING AEROSOLIZED NITRITE AND NITRIC OXIDE AND USES THEREOF
WO2009116944A1 (en) * 2008-03-20 2009-09-24 Krister Tano Use of a substance for manufacturing of a medicament for treatment of common cold
WO2019005901A1 (en) * 2017-06-27 2019-01-03 Ohio State Innovation Foundation Liponucleotide-based therapy for asthma
CN109432122A (zh) * 2018-11-19 2019-03-08 罗辉 No或no供体在制备预防和/或治疗皮肤疾病或黏膜疾病药物中的应用及药物组合物
CN109846113A (zh) * 2018-11-29 2019-06-07 南京诺全生物医疗科技有限公司 一种可自提供一氧化氮的口鼻卫生用品
EP4093205A4 (en) * 2020-02-07 2024-02-21 KNOW Bio, LLC Nitric oxide-releasing antibacterial compounds, formulations, and methods pertaining thereto

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5455279A (en) * 1991-04-19 1995-10-03 The Children's Medical Center Corporation Regimen method of mediating neuronal damage using nitroglycerine

Also Published As

Publication number Publication date
KR20010021749A (ko) 2001-03-15
TR200000157T2 (tr) 2001-06-21
AU8399098A (en) 1999-02-08
US6277891B1 (en) 2001-08-21
HUP0002859A2 (hu) 2001-01-29
CA2303430A1 (en) 1999-01-21
JP2001509481A (ja) 2001-07-24
WO1999002148A1 (en) 1999-01-21
NO20000151D0 (no) 2000-01-11
CZ200092A3 (en) 2001-05-16
CN1277552A (zh) 2000-12-20
ID23780A (id) 2000-05-11
EP1011657A1 (en) 2000-06-28
NO20000151L (no) 2000-03-09

Similar Documents

Publication Publication Date Title
BR9811473A (pt) Infecção por rinovìrus inibida por óxido nìtrico
CO5200855A1 (es) Uso de csaids en infecciones por rinovirus
CL2008003938A1 (es) Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden de estres postraumatico (divisional sol. 1799-00).
BR9811825A (pt) Uso de lactobacillus para redução do nìvel de fibrinogênio no sangue
KR960703009A (ko) 중추유래의 수면성 무호흡증 및 호흡곤란증의 치료를 위한 모다피닐의 사용
AU4722785A (en) Initiating reperfusion treatment when heart attack symptoms are present
BR0107565A (pt) Formas de dosagem de benzimidazol substituìdo e método de emprego das mesmas
DE69230037D1 (de) Kontinuierliche zellinie sowie impfstoff gegen geflügelinfektion mit kokkidien
PT1261333E (pt) Utilizacao de topiramato para o tratamento e diagnostico de transtorno do sono relacionado com a respiracao e meios para realizar o metodo e o diagnostico
KR950701820A (ko) 패혈증 및 패혈증-연관 옹고장애의 예방 및 치료(prophylaxs and treatment of sepsis and sepsis-associated coagulation disorders)
BR9815098A (pt) Uso de mirtazapina ou de um seu sal farmaceuticamente aceitável, e, processo para o tratamento de apnéias do sono em um aninal.
ATE360428T1 (de) Analgetisches arzneimittel
BR9813641A (pt) &#34;preparados transmucosais de levosimendan&#34;
PT81387B (pt) Processo para a preparacao de composicoes farmaceuticas contendo 1-beta-d-ribofuranosil-1,2,4-triazole-3-carboxamida, uteis no tratamento de doencas provocadas por virus em seres humanos
KR910015300A (ko) 부스피론 : 수면 무호흡증의 치료용도
ES2090167T3 (es) Uso topico de glicosaminoglicanos en la prevencion y el tratamiento de enfermedades que afectan al tracto vaginal cervical.
PT859613E (pt) Utilizacao de flupirtina para a profilaxia e o tratamento de doencas associadas a uma alteracao do sistema celular hematopoietico
MY124071A (en) Treatment of viral disease in swine
PT100284A (pt) Anti-helmintico de benzimidazol para uso no fabrico de um medicamento para o tratamento de infeccao microsporideos
DK0740657T3 (da) 4-Arylisoindoler med analgetisk virkning
KR950702838A (ko) 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4)
BR0316059A (pt) Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise
NO951608D0 (no) Anvendelse av BHAP-forbindelser i kombinasjon med andre ikke-nukleoside reverstranskriptaseinhibitorer for behandling av HIV-infeksjon
DK1143976T3 (da) Beta-D-2&#39;, 3&#39;-didehydro-2&#39;, 3&#39;-dideoxy-5-fluorcytidin til anvendelse i behandlingen af HIV-infektioner
ATE112489T1 (de) Extrakte von acanthospermum hispidum-pflanzen.

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]